Danaher Corporation $DHR Shares Bought by AEGON ASSET MANAGEMENT UK Plc

AEGON ASSET MANAGEMENT UK Plc lifted its position in Danaher Corporation (NYSE:DHR) by 18.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 181,218 shares of the conglomerate’s stock after acquiring an additional 28,381 shares during the period. AEGON ASSET MANAGEMENT UK Plc’s holdings in Danaher were worth $35,897,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently added to or reduced their stakes in DHR. WFA of San Diego LLC purchased a new stake in shares of Danaher in the 2nd quarter valued at approximately $26,000. Howard Hughes Medical Institute purchased a new stake in Danaher in the 2nd quarter valued at $27,000. TruNorth Capital Management LLC acquired a new stake in Danaher during the 3rd quarter worth approximately $28,000. Red Tortoise LLC increased its stake in shares of Danaher by 175.0% during the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after acquiring an additional 98 shares during the period. Finally, Tripletail Wealth Management LLC purchased a new position in Danaher in the third quarter worth $31,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of NYSE DHR opened at $234.91 on Monday. The business’s 50-day moving average price is $230.26 and its two-hundred day moving average price is $213.26. Danaher Corporation has a one year low of $171.00 and a one year high of $258.23. The company has a market capitalization of $165.93 billion, a P/E ratio of 48.43, a price-to-earnings-growth ratio of 3.58 and a beta of 0.89. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a dividend of $0.32 per share. The ex-dividend date is Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.5%. Danaher’s payout ratio is 26.39%.

Analyst Ratings Changes

DHR has been the topic of several research reports. Robert W. Baird set a $247.00 price target on shares of Danaher in a research report on Wednesday, October 22nd. Evercore ISI restated an “outperform” rating and set a $250.00 price objective on shares of Danaher in a research note on Monday, January 5th. Rothschild Redb downgraded shares of Danaher from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 8th. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a report on Saturday, November 22nd. Finally, Barclays increased their price target on shares of Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. Twenty research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $252.09.

Insider Transactions at Danaher

In related news, Director Teri List sold 3,298 shares of Danaher stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the sale, the director directly owned 20,762 shares of the company’s stock, valued at $4,702,593. This trade represents a 13.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the sale, the senior vice president owned 14,553 shares in the company, valued at approximately $3,190,454.19. This trade represents a 59.94% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 30,248 shares of company stock worth $6,609,663. 11.20% of the stock is currently owned by company insiders.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.